Viewing Study NCT00207766


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-02 @ 10:02 AM
Study NCT ID: NCT00207766
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Sponsor: Centocor, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-06
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-08
Completion Date Type: ACTUAL
First Submit Date: 2005-09-13
First Submit QC Date: None
Study First Post Date: 2005-09-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-04-26
Last Update Post Date: 2010-04-27
Last Update Post Date Type: ESTIMATED